Alexa S. Green

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Non-genetic remodeling drives leukemia propagation and reveals actionable vulnerabilities in acute myeloid leukemia.

Journal: Cell reports. Medicine
Published: June 20, 2025

Don't judge lymphocytosis by its flow.

Don't judge lymphocytosis by its flow.

Journal: Blood
Published: June 04, 2021

Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy.

Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy.

Journal: Leukemia & lymphoma
Published: August 29, 2020

Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDS.

Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDS.

Journal: Cytometry. Part B, Clinical cytometry
Published: March 28, 2019

A pernicious mean corpuscular volume.

A pernicious mean corpuscular volume.

Journal: Blood
Published: January 27, 2018

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.

Journal: Leukemia
Published: May 10, 2017

FLT3 inhibitors: clinical potential in acute myeloid leukemia.

FLT3 inhibitors: clinical potential in acute myeloid leukemia.

Journal: OncoTargets and therapy
Published: February 23, 2017

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

Journal: Science advances
Published: February 23, 2015

Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.

Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.

Journal: Cell reports
Published: December 26, 2014

Targeting CHK1 inhibits cell proliferation in FLT3-ITD positive acute myeloid leukemia.

Targeting CHK1 inhibits cell proliferation in FLT3-ITD positive acute myeloid leukemia.

Journal: Leukemia research
Published: February 24, 2014

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

Journal: Blood
Published: September 10, 2013

Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity.

Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity.

Journal: International journal of obesity (2005)
Published: September 21, 2012
Showing 1-12 of 17

Last Updated: 09/26/2026